WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMGN past earnings growth

How has AMGN's earnings growth performed historically?
Company
-60.82%
Industry
53.99%
Market
54.69%
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMGN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMGN past revenue growth

How has AMGN's revenue growth performed historically?
Company
16.37%
Industry
11.03%
Market
17.56%
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMGN earnings and revenue history

Current Revenue
$30.9B
Current Earnings
$3.1B
Current Profit Margin
10.1%
AMGN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

AMGN Return on Equity

Current Company
50.4%
Current Industry
38.5%
Current Market
33.8%
AMGN's Return on Equity (50.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMGN announces earnings.

AMGN Return on Assets

Current Company
3.4%
Current Industry
9.5%
AMGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMGN Return on Capital Employed

Current Company
9.71%
Current Industry
16.2%
AMGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMGN vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMGN$30.93B$11.81B$3.13B+5.60%-14.36%
PFE$55.64B$2.50B-$2.60B+6.38%N/A
SNY$51.52B$12.48B$4.58B+4.06%+2.13%
NVS$48.86B$27.27B$16.18B+0.88%+9.89%
AZN$49.13B$14.57B$6.44B+16.32%+19.26%
View Top General Drug Manufacturer Stocks

AMGN earnings dates

Next earnings date
Oct 29, 2024

Amgen Earnings & Revenue FAQ

What were AMGN's earnings last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q2 2024 earnings per share (EPS) of $1.39, up 46.12% year over year. Total Amgen earnings for the quarter were $746.00 million. In the same quarter last year, Amgen's earnings per share (EPS) was $2.58.

If you're new to stock investing, here's how to buy Amgen stock.

What was AMGN's earnings growth in the past year?

As of Q3 2024, Amgen's earnings has grown -60.82% year over year. This is 114.8 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 53.99%. Amgen's earnings in the past year totalled $3.13 billion.

What is AMGN's earnings date?

Amgen's earnings date is Invalid Date. Add AMGN to your watchlist to be reminded of AMGN's next earnings announcement.

What was AMGN's revenue last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q2 2024 revenue of $8.39 billion up 20.07% year over year. In the same quarter last year, Amgen's revenue was $6.99 billion.

What was AMGN's revenue growth in the past year?

As of Q3 2024, Amgen's revenue has grown 16.37% year over year. This is 5.34 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 11.03%. Amgen's revenue in the past year totalled $30.93 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.